Forsythin
CAS No. 487-41-2
Forsythin( —— )
Catalog No. M14639 CAS No. 487-41-2
Extracted from Forsythia suspensa;Suitability:The mixed solvent of chloroform and methanol,DMSO;Store the product in sealed,cool and dry condition.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 116 | In Stock |
|
| 50MG | 169 | In Stock |
|
| 100MG | 255 | In Stock |
|
| 500MG | 619 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameForsythin
-
NoteResearch use only, not for human use.
-
Brief DescriptionExtracted from Forsythia suspensa;Suitability:The mixed solvent of chloroform and methanol,DMSO;Store the product in sealed,cool and dry condition.
-
DescriptionExtracted from Forsythia suspensa;Suitability:The mixed solvent of chloroform and methanol,DMSO;Store the product in sealed,cool and dry condition.(In Vitro):Phillyrin (1–5 μM; pretreatment 1 hour; 24 hours) inhibits high glucose-induced FAS protein significantly in HepG2 cells.Phillyrin (1–5 μM; pretreatment 1 hour; 24 hours) inhibits high glucose-induced FAS mRNA expression by suppressing SREBP-1c activation in human HepG2 hepatocytes.
-
In VitroPhillyrin (1–5 μM; pretreatment 1 hour; 24 hours) inhibits high glucose-induced FAS protein significantly in HepG2 cells.Phillyrin (1–5 μM; pretreatment 1 hour; 24 hours) inhibits high glucose-induced FAS mRNA expression by suppressing SREBP-1c activation in human HepG2 hepatocytes. RT-PCR Cell Line:Human HepG2 hepatocyte cells Concentration:1 μM; 2.5 μM; 5 μM Incubation Time:24 hours Result:Reduced FAS and SREBP-1c mRNA expression.
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38 MAPK
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number487-41-2
-
Formula Weight534.56
-
Molecular FormulaC27H34O11
-
Purity>98% (HPLC)
-
SolubilityDMSO: Soluble
-
SMILESCOC1=C(OC)C=C(C=C1)C1OCC2C1COC2C1=C(OC)C=C(OC2OC(CO)C(O)C(O)C2O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pan X, et al. Inflamm Res. 2014 Jul;63(7):597-608.
molnova catalog
related products
-
SM1-71
SM1-71 is a potent multi-targeted acrylamide-modified TAK1 inhibitor that inhibits MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2.
-
SB 202190
SB 202190 (SB202190, SB-202190) is a potent inhibitor p38α and p38β with IC50 of 50 nM and 100 nM respectively.
-
Ro-3201195
Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
Cart
sales@molnova.com